FDA Logo links to FDA home page Skip Navigation
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website
horizonal rule
Dockets Management


CP 1
Volume 1

Citizen Petition

Tab A - Metcalf Pharmacy website, http://www.metcalfpharmacy.com/nhrt.htm Published Material

Tab B - Requirement for Labeling Directed to the Patient, 42 Fed. Reg. 37636, 37637 (July 22, 1977)
(codified at 21 C.F.R. S 310.515)

Tab C - Handouts on bioidentical hormones, provided by Mary M. Morton, FNP-C

Tab D - Brochure for Health Max Pharmacy Regional Symposium on Bio-Identical Hormone Replacement Therapy (N.Y., Apr. 30, 2005)

Tab E - Scarbrough Medical Arts Pharmacy’s "Dear Doctor" letter

Tab F - Silverbow Rx Compounding Pharmacy's promotional materials Bio-Identical Hormones: Customized Replacement Therapy to Meet the Needs of Each Woman & Man

Tab G - PenCol Medisave Pharmacy promotional materials Beginning or Conversion to Bio-Identical Hormone Replacement Therapy (BHRT)

Tab H - The Medicine Shoppe’s Oct. 10, 2001, "Dear Doctor" letter

Tab I - Rancho Park Compounding Pharmacy's promotional materials Bio-Identical Hormone Replacement Therapy for Women

Tab J - Red River Pharmacy Services’ "Dear Doctor" letter

Tab K - Women's Health America/Madison Pharmacy Associates website, http://www.womenshealth.com/estrogen_therapy.html Published Material

Tab L - H.R Conf. Rep. No. 105-399, at 94 (1997), as reprinted in, 1997 U.S.C.C.A.N. 2880, 2884

Tab M - IACP, Legal and Ethical Advertising of Compounded Medications, http://www.iacprx.org/pdf/legal_and_ethical.pdf

Tab N - IACP, Code of Ethics, http://www.iacprx.org/pdf/ethics.pdf

Tab O - 21 U.S.C. 353(b)(2); S. Rep. No. 82-946 (1951), as reprinted in, 1951 U.S.C.C.A.N. 2454, 2462-63

Tab P - H.R. Rep. No. 82-700, at 16 (1951)

Top | Back

Page last updated October 26, 2005 RSChorizonal rule
Dockets Home Page | Dockets Contacts and Location | Operating Status | Item Code Definitions | Federal Register
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA

FDA/Dockets Management